Refocus Group, Inc. (RFCS) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Dallas, TX, アメリカ. 現CEOは J. Michael Judy.
RFCS を有する IPO日 2003-03-07, 4 名の正社員, に上場 Other OTC, 時価総額 $25.00.
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
